[PLX] YoY Quarter Result on 30-Jun-2012 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
03-Aug-2012
Financial Year
2012
Quarter
30-Jun-2012 [#Q2]
Profit Trend
QoQ- 263.31%
YoY- 170.44%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 4,616 2,686 3,064 26,113 764 1,141 0 -
PBT -5,071 -6,119 -6,837 22 179 0 0 -
Tax 43 202 0 -8,765 20,699 -109 -446 -
NP -5,071 -6,119 -6,837 9,642 -13,689 -10,041 -5,427 -1.12%
Tax Rate - - - 39,840.91% -11,563.69% - - -
Total Cost 9,687 8,805 9,901 16,471 14,453 11,182 5,427 10.13%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin -109.86 -227.81 -223.14 36.92 -1,791.75 -880.02 0.00 -
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
EPS -0.05 -0.07 -0.07 0.11 -0.16 -0.12 -0.07 -5.45%
EPS Diluted -0.05 -0.07 -0.07 0.10 -0.16 -0.12 -0.07 -5.45%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.